• 44% increase in revenue versus prior corresponding period
• 41% growth in recurring revenue driven by new customer wins and contract expansions
• Underlying EBITDA up 675% to $4.2M, reflecting emerging operating leverage

Alcidion Group Ltd reported a strong H1 FY26, with revenue increasing 44% to $25.5M compared to the prior corresponding period. This growth was driven by a 41% increase in recurring revenue, which now accounts for 76% of total revenue, as well as a 32% rise in non-recurring revenue from major deployments. Gross profit margin increased 37% to $21.0M, with the company's gross margin remaining high at 83%. Underlying EBITDA grew 675% to $4.2M, reflecting the company's emerging operating leverage as it reaches scale. The company also reported a maiden H1 NPAT of $1.3M, a significant improvement from the $0.9M loss in the prior corresponding period. Alcidion's financial performance was underpinned by strong sales momentum, with several contract expansions and renewals, including a partnership with Mizaic for electronic document management at North Cumbria NHS Trust and an expansion of the Leidos Australia contract to include additional Miya Precision and Medications management capability. The company also received industry recognition, with Miya Precision customers nominated for six prestigious awards at the 2026 HSJ Digital Awards.

Alcidion is forecasting FY26 revenue of $50M, with contracted FY26 revenue of $43.1M as of 31 December 2025. The company maintains a capital-light business model with negligible capex and a strong cash position of $14.2M and no debt.

Alcidion is well-positioned to continue its strong growth trajectory, driven by increasing adoption of its Miya Precision platform, expansion within existing customers, and new customer wins across its target markets. The company is also exploring opportunities to expand into new geographies, such as Canada and the Middle East, to further diversify its global footprint.